Micro-orchestrating differentiation in cancer

Cell Cycle

Volumn 9, Issue 5, 2010, Pages 918-922

  Taulli, Riccardo ^a   Bersani, Francesca ^a   Ponzetto, Carola ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Differentiation therapy; Epigenetics; microRNAs; Rhabdomyosarcoma

Indexed keywords

MICRORNA; MICRORNA 124; MICRORNA 137; MICRORNA 206; MICRORNA 29; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CANCER CELL; CELL CYCLE ARREST; CELL DIFFERENTIATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENETIC REGULATION; GENETIC VARIABILITY; GLIOBLASTOMA; HEMATOLOGIC MALIGNANCY; HUMAN; NONHUMAN; PHENOTYPE; REVIEW; RHABDOMYOSARCOMA; TRANSCRIPTION INITIATION;

EID: 77953524459     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.5.10864     Document Type: Review

References (40)

1. Gurdon JB, Uehlinger V. "Fertile" intestine nuclei. Nature 1966; 210:1240-1.
2. Campbell KH, McWhir J, Ritchie WA, Wilmut I. Sheep cloned by nuclear transfer from a cultured cell line. Nature 1996; 380:64-6.
3. Yamanaka S. A fresh look at iPS cells. Cell 2009; 137:13-7.
4. Zhao XY, Li W, Lv Z, Liu L, Tong M, Hai T, et al. iPS cells produce viable mice through tetraploid complementation. Nature 2009; 461:86-90.
5. Boland MJ, Hazen JL, Nazor KL, Rodriguez AR, Gifford W, Martin G, et al. Adult mice generated from induced pluripotent stem cells. Nature 2009; 461:91-4.
6. Sparmann A, van Lohuizen M. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 2006; 6:846-56.
7. Bracken AP, Helin K. Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer 2009; 9:773-84.
8. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-33.
9. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433:769-73.
10. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10:704-14.
11. Valastyan S, Weinberg RA. MicroRNAs: Crucial multi-tasking components in the complex circuitry of tumor metastasis. Cell Cycle 2009; 8:3506-12.
12. Rossi JJ. New hope for a microRNA therapy for liver cancer. Cell 2009; 137:990-2.
13. Mishra PJ, Merlino G. MicroRNA reexpression as differentiation therapy in cancer. J Clin Invest 2009; 119:2119-23.
14. Petrocca F, Lieberman J. Micromanipulating cancer: microRNA-based therapeutics? RNA Biol 2009; 6:335-40.
15. Lieberman J. Micromanaging cancer. N Engl J Med 2009; 361:1500-1.
16. Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, Cigudosa JC, et al. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 2008; 13:496-506.
17. Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451:147-52.
18. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szász AM, Wang ZC, et al. miR-31, inhibits breast cancer metastasis. Cell 2009; 137:1032-46.
19. Valastyan S, Benaich N, Chang A, Reinhardt F, Weinberg RA. Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis. Genes Dev 2009; Epub ahead of print.
20. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009; 137:1005-17.
21. Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B, et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 2008; 322:1695-9.
22. Caretti G, Di Padova M, Micales B, Lyons GE, Sartorelli V. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev 2004; 18:2627-38.
23. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006; 38:228-33.
24. Wong CF, Tellam RL. MicroRNA-26a targets the histone methyltransferase. Enhancer of Zeste homolog 2 during myogenesis. J Biol Chem 2008; 283:9836-43.
25. Juan AH, Kumar RM, Marx JG, Young RA, Sartorelli V. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell 2009; 36:61-74.
26. Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J, et al. NFkappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 2008; 14:369-81.
27. Yoo AS, Staahl BT, Chen L, Crabtree GR. MicroRNA-mediated switching of chromatin-remodelling complexes in neural development. Nature 2009; 460:642-6.
28. Merlino G, Helman LJ. Rhabdomyosarcoma - working out the pathways. Oncogene 1999; 18:5340-8.
29. Tapscott SJ, Thayer MJ, Weintraub H. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science 1993; 259:1450-3.
30. Ciarapica R, Russo G, Verginelli F, Raimondi L, Donfrancesco A, Rota R, Giordano A. Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma. Cell Cycle 2009; 8:172-5.
31. Taulli R, Bersani F, Foglizzo V, Linari A, Vigna E, Ladanyi M, et al. J Clin Invest 2009; 119:2366-78.
32. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 2007; 104:15805-10.
33. Kim HK, Lee YS, Sivaprasad U, Malhotra A, Dutta A. Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol 2006; 174:677-87.
34. Taulli R, Scuoppo C, Bersani F, Accornero P, Forni PE, Miretti S, et al. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma. Cancer Res 2006; 66:4742-9.
35. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433:769-73.
36. Ivey KN, Muth A, Arnold J, King FW, Yeh RF, Fish JE, et al. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell 2008; 2:219-29.
37. Song G, Wang L. Nuclear receptor SHP activates miR-206 expression via a cascade dual inhibitory mechanism. PLoS One 2009; 4:6880.
38. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 2008; 6:14.
39. Laé M, Ahn EH, Mercado GE, Chuai S, Edgar M, Pawel BR, et al. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas. J Pathol 2007; 212:143-51.
40. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70.